| Literature DB >> 28165428 |
Hsin-Yi Chen1, Hsiu-Chuan Chou2,3,4, Shing-Jyh Chang5, En-Chi Liao6, Yi-Ting Tsai7, Yu-Shan Wei8, Ji-Min Li9, Li-Hsun Lin10, Meng-Wei Lin11, Ying-Jen Chen12, Yu-Sheng Chen13, Chih-Chun Lin14, Yi-Shiuan Wang15, Mei-Lan Ko16,17, Hong-Lin Chan18.
Abstract
Glaucoma is a group of eye diseases that can cause vision loss and optical nerve damage. To investigate the protein expression alterations in various intraocular tissues (i.e., the cornea, conjunctiva, uvea, retina, and sclera) during ischemia-reperfusion (IR) injury, this study performed a proteomic analysis to qualitatively investigate such alterations resulting from acute glaucoma. The IR injury model combined with the proteomic analysis approach of two-dimensional difference gel electrophoresis (2D-DIGE) and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) was used to monitor the protein expression alterations in two groups of specimens (an IR injury group and a control group). The analysis results revealed 221 unique differentially expressed proteins of a total of 1481 proteins in the cornea between the two groups. In addition, 97 of 1206 conjunctival proteins, 90 of 1354 uveal proteins, 61 of 1180 scleral proteins, and 37 of 1204 retinal proteins were differentially expressed. These findings imply that different ocular tissues have different tolerances against IR injury. To sum up, this study utilized the acute glaucoma model combined with 2D-DIGE and MALDI-TOF MS to investigate the IR injury affected protein expression on various ocular tissues, and based on the ratio of protein expression alterations, the alterations in the ocular tissues were in the following order: the cornea, conjunctiva, uvea, sclera, and retina.Entities:
Keywords: acute glaucoma; cornea; difference gel electrophoresis (DIGE); ischemia–reperfusion (IR) model; matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF); proteomics
Mesh:
Substances:
Year: 2017 PMID: 28165428 PMCID: PMC5343869 DOI: 10.3390/ijms18020334
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Comparison of proteomics between the ischemia–reperfusion (IR) injury and control groups (Ctrl) in cornea. MW: molecular weight (A) Schematic representation of the two-dimensional difference gel electrophoresis (2D-DIGE) workflow for monitoring the differentially expressed proteins in the cornea of the IR injury and control groups, and Cy2 pool represents the total protein spots; (B) 2D-DIGE images of the tissue samples analyzed using DeCyder software; the differentially expressed identified protein features are annotated with circles and spot numbers.
Figure 2Comparison of proteomics between the IR injury and control groups in conjunctiva. (A) Schematic representation of the 2D-DIGE workflow for monitoring the differentially expressed proteins in the conjunctiva of the IR injury and control groups; (B) 2D-DIGE images of the tissue samples analyzed using DeCyder software; the differentially expressed identified protein features are annotated with circles and spot numbers.
Figure 3Comparison of proteomics between the IR injury and control groups in uvea. (A) Schematic representation of the 2D-DIGE workflow for monitoring the differentially expressed proteins in the uvea of the IR injury and control groups; (B) 2D-DIGE images of the tissue samples analyzed using DeCyder software; the differentially expressed identified protein features are annotated with circles and spot numbers.
Figure 4Comparison of proteomics between the IR injury and control groups in sclera. (A) Schematic representation of the 2D-DIGE workflow for monitoring the differentially expressed proteins in the sclera of the IR injury and control groups; (B) 2D-DIGE images of the tissue samples analyzed using DeCyder software; the differentially expressed identified protein features are annotated with circles and spot numbers.
Figure 5Comparison of proteomics between the IR injury and control groups in retina. (A) Schematic representation of the 2D-DIGE workflow for monitoring the differentially expressed proteins in the retina of the IR injury and control groups; (B) 2D-DIGE images of the tissue samples analyzed using DeCyder software; the differentially expressed identified protein features are annotated with circles and spot numbers.
Order of protein expression alterations (i.e., cornea, conjunctiva, uvea, sclera, and retina) according to the ratio of protein expression alterations.
| Ocular Tissues | ≥1.3 or ≤−1.3 (Fold Change) | Ratio (%) | Rankings |
|---|---|---|---|
| cornea | 221/1481 | 14.92% | 1 |
| conjunctiva | 97/1206 | 8.04% | 2 |
| uvea | 90/1354 | 6.65% | 3 |
| sclera | 61/1180 | 5.17% | 4 |
| retina | 37/1204 | 2.49% | 5 |
Figure 6Percentage of total cellular proteins identified by 2D-DIGE/matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) for (A) cornea; (B) conjunctiva; (C) uvea; (D) sclera; and (E) retina according to their biological functions.
Figure 7Representative immunoblotting analysis for selected differentially expressed protein identified by proteomic analysis between control groups and ischemia-reperfusion groups. The levels of identified proteins, Aldehyde dehydrogenase, dimeric dimeric nicotinamide adenine dinucleotide phosphate (NADP)-preferring, confirmed by immunoblot (top panels), with LDH (Lactate dehydrogenase) as loading controls. Protein expression map and three-dimension spot image are also shown. (The pink lines annotate the particular spot).